Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Edwards

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of MS Care|December 23, 2017
Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple SclerosisZilfah Younus, Caila B Vaughn, Shaik Ahmed Sanai, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
BMC Pharmacology & Toxicology|July 29, 2019
Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trialChristine Wigger, Amanda Jane Leach, Jemima Beissbarth, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2014
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine productionXiu Teng, Zhonglan Hu, Xiaoqiong Wei, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
Plant Molecular Biology|May 15, 2002
Development and mapping of SSR markers for maizeNatalya Sharopova, Michael D McMullen, Linda Schultz, et al.
JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of MS Care|December 23, 2017
Fatigue and Mood States in Nursing Home and Nonambulatory Home-Based Patients with Multiple SclerosisZilfah Younus, Caila B Vaughn, Shaik Ahmed Sanai, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 24, 2017
Safety/tolerability of the anti-semaphorin 4D Antibody VX15/2503 in a randomized phase 1 trialChristopher LaGanke, Lawrence Samkoff, Keith Edwards, et al.
BMC Pharmacology & Toxicology|July 29, 2019
Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trialChristine Wigger, Amanda Jane Leach, Jemima Beissbarth, et al.
Multiple Sclerosis and Related Disorders|December 19, 2021
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability DataSamantha Epstein, Zongqi Xia, Annie J Lee, et al.
Multiple Sclerosis and Related Disorders|January 11, 2022
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemicElle Levit, Inessa Cohen, Megan Dahl, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 24, 2014
IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine productionXiu Teng, Zhonglan Hu, Xiaoqiong Wei, et al.
Neurology. Clinical Practice|May 1, 2018
Effectiveness of alternative dose fingolimod for multiple sclerosisErin E Longbrake, Daniel Kantor, Siddharama Pawate, et al.
Plant Molecular Biology|May 15, 2002
Development and mapping of SSR markers for maizeNatalya Sharopova, Michael D McMullen, Linda Schultz, et al.
JAMA Neurology|March 11, 2024
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne H Cross, Jeffrey M Gelfand, Simon Thebault, et al.
Pageof 4